To address this, we explored the hypothesis that Keap1/Nrf2 mutations in head and neck stem and progenitor cells were linked to frequent lung metastasis, aggressive tumor behavior, and failure of chemoradiation, and in some cases, targeted therapy. This evidence concerns the gene KEAP1 and neoplasm.